Home > Category > Signaling Pathways > JAK/STAT Signaling > JAK > Deucravacitinib (Synonyms: BMS-986165)

Deucravacitinib (Synonyms: BMS-986165)

ChemLeader Purity: 99.73%
Catalog No:CL2962 CAS No.:1609392-27-9 MDLNo:MFCD31715455 Formula:C20H19D3N8O3 MW:425.46
Size Availability Price(USD) VIP Price (USD) Quantity
1 mg In-stock $78.00 Visible after login
- +
5 mg In-stock $188.00 Visible after login
- +
10 mg In-stock $348.00 Visible after login
- +
25 mg In-stock $618.00 Visible after login
- +
50 mg In-stock $906.00 Visible after login
- +
100 mg In-stock $1276.00 Visible after login
- +
250 mg In-stock $1638.00 Visible after login
- +
500 mg In-stock $2256.00 Visible after login
- +
1 g In-stock $3656.00 Visible after login
- +

Chemical safety data sheet(MSDS)

Download MSDS

Certificate Of Authenticity(CPA)

  • Product Overview
  • Related documents
  • Product details
  • Related literature
Product Overview
Product Name Deucravacitinib (Synonyms: BMS-986165)
CAS1609392-27-9
FormulaC20H19D3N8O3
MW425.46
MDLMFCD31715455
AppearanceOff-white to light yellow powder
Storage conditionStore in a dry and dark sealed container, short-term (weeks to months) storage at 0-4 ℃, long-term (months to years) storage at -20 ℃.
Product details

Deucravacitinib (BMS-986165) inhibits IL-12/23 and type I IFN pathways. BMS-986165 is a highly selective, orally bioavailable allosteric TYK2 inhibitor for the treatment of autoimmune diseases. Which selectively binds to TYK2 pseudokinase (JH2) domain (IC50=1.0 nM) and blocks receptor-mediated Tyk2 activation by stabilizing the regulatory JH2 domain.


Related
Sorry, no related items
Service
ChemLeader
021-58180488
Online service time: 9:00-18:00 on weekdays